LY-3073034

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLY-3073034
Drug Alias NameLY-3073034LY-3073084
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGhrelin O-acyltransferase inhibitors
TargetsGhrelin O-acyltransferase
Therapy Area/IndicationsDiabetes Mellitus, Type 2Parkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Parkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A